Test Price
2,800 AED✅ Home Collection Available
OTOF Gene Deafness (Autosomal Recessive Type 9) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين OTOF للصمم الوراثي المتنحي من النوع 9 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
ملخص تنفيذي: اختبار الجين OTOF بتسلسل الجيل التالي دقة تشخيصية 99.9% عبر مختبر معتمد، خدمة سحب منزلي فاخرة، استشارة هاتفية بعد النتيجة، وتأمين عبر الواتساب.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing
- Premium Logistics: Hospital-Grade Home Collection via ISO Certified Cold-Chain
- VIP Mobile Phlebotomy: 8 AM – 11 PM, 7 days a week
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Overview
The OTOF Gene NGS Test identifies pathogenic variants in the OTOF gene linked to autosomal recessive nonsyndromic hearing loss (DFNB9) with 99.9% diagnostic accuracy. يكشف هذا الاختبار الطفرات الجينية المسببة للصمم الوراثي المتنحي من النوع 9، مما يسهل التدخل المبكر والتخطيط للعلاج.
This comprehensive genetic test uses Next Generation Sequencing to analyze the entire OTOF gene for pathogenic variants, enabling precise diagnosis and personalized management, including cochlear implantation evaluation.
| Feature | Our OTOF NGS Test | Alternative (Single-Gene Sanger) |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) | Sanger Sequencing |
| Detection Rate | >99.9% for point mutations, indels, CNVs | ~95% for known variants only |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Sample Options | Blood, Extracted DNA, FTA Card | Blood or DNA only |
| Genetic Counseling | Included (Pre & Post-Test) | Often Limited |
| DHA Accreditation | Yes (Facility License 9834453) | Variable |
Physician Insight & Safety Protocol
“As an ENT and genetic hearing loss specialist, I consider the OTOF NGS test a cornerstone for early diagnosis of DFNB9, especially when cochlear implantation is being evaluated. Please remember that this genetic result must be correlated with comprehensive audiological assessment and family history. Never make treatment decisions without consulting your supervising clinician.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
Medication Warning:
Do not discontinue any prescribed medication or alter therapy without explicit guidance from your physician. Genetic results do not replace clinical management.
Safety Exclusion Criteria & Red Flags
- Exclusion Criteria: Severe coagulopathy, active bacteremia, or inability to provide informed written consent (including minors without guardian consent as per UAE CDS Law 2026).
- Red Flags After Blood Draw: Seek emergency care if you experience excessive bleeding, hypotension, syncope, or signs of infection (redness, swelling, pus) at the puncture site.
- Minors: Genetic testing for individuals under 18 requires parental/legal guardian consent and genetic counseling according to UAE Federal Decree-Law No. 41 of 2024, Art. 87.
UAE Privacy Compliance: All genetic and personal data handled as per UAE Personal Data Protection Law (PDPL), stored within UAE servers, and not shared without consent. Testing complies with Federal Decree-Law No. 41 of 2024, Art. 87 for minors and CDS Law 2026.
Pre-Test Requirements
A genetic counseling session with a clinical geneticist/ENT physician is mandatory before testing. Provide detailed clinical history of hearing loss (age of onset, audiogram results, family history). A pedigree chart will be drawn to identify at-risk relatives. No fasting is required; sample can be whole blood in EDTA tube, one drop of blood on FTA card, or previously extracted DNA.
Patient FAQ & Clinical Guidance
What is the OTOF gene test and why is it needed?
Snippet killer: It detects mutations in the OTOF gene causing autosomal recessive nonsyndromic hearing loss DFNB9 to guide cochlear implant candidacy.
This test is essential for newborns and children with unexplained bilateral sensorineural hearing loss, as OTOF mutations account for a significant proportion of genetic deafness. Identifying a biallelic mutation confirms the diagnosis and helps predict excellent outcomes with cochlear implantation, avoiding unnecessary diagnostic odysseys.
يكشف هذا الاختبار طفرات جين OTOF المسببة لفقدان السمع الوراثي المتنحي من النوع 9، مما يحدد أهلية زراعة القوقعة ويوجه الاستشارة الوراثية للعائلة.
How accurate is this NGS test and what do the results mean?
Snippet killer: The offers 99.9% analytical sensitivity for detecting all pathogenic variants in the OTOF gene through NGS.
Results are classified as positive (two pathogenic mutations found, confirming DFNB9), negative, or variant of uncertain significance (VUS). Our genetic counselor will explain implications for hearing rehabilitation, including cochlear implant timing, and offer family risk assessment for future pregnancies.
دقة الاختبار تصل إلى 99.9% في الكشف عن التغيرات المرضية في الجين، ويتم تفسير النتائج بواسطة استشاري وراثي لوضع خطة العلاج المناسبة.
How is the sample collected? Is home collection available?
Snippet killer: A simple blood draw or FTA card finger stick can be collected at home by a DHA-licensed phlebotomist.
We provide VIP home collection service from 8 AM to 11 PM daily. The sample is transported in cold-chain packaging to our ISO 9001:2015 certified laboratory. You can also submit extracted DNA if previously stored. The whole process is painless and toddler-friendly, with results ready in 3–4 weeks.
يمكن سحب العينة في المنزل عبر خدمة السحب المنزلي الفاخرة على مدار اليوم، وتنقل بتبريد معتمد إلى المختبر لتحليلها خلال 3 إلى 4 أسابيع.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians